Conatus Pharmaceuticals rises sharply

|About: Conatus Pharmaceuticals (CNAT)|By:, SA News Editor

Shares of Conatus Pharmaceuticals (CNAT) look set to ride ICPT's coattails to another banner session.

The shares rallied 57% Thursday on optimism for liver disease treatment plays, fueled by ICPT's success in NASH.

CNAT +29% premarket.